Alembic Pharmaceuticals Limited (NSE:APLLTD)
India flag India · Delayed Price · Currency is INR
1,044.00
+14.05 (1.36%)
Nov 12, 2026, 3:29 PM IST

Alembic Pharmaceuticals Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
205,212130,370182,755193,57597,564145,771
Market Cap Growth
13.86%-28.66%-5.59%98.41%-33.07%-23.15%
Enterprise Value
217,985143,795192,124200,785104,548151,109
Last Close Price
1047.25653.53906.05949.00473.08696.10

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
24.3119.3231.3331.4328.5327.98
Forward PE
21.4016.1525.3728.7119.1519.76
PS Ratio
2.421.782.743.111.732.75
PB Ratio
3.462.303.524.022.232.78
P/TBV Ratio
3.692.423.524.022.232.87
P/FCF Ratio
35.2837.45-40.6934.78115.04
P/OCF Ratio
21.5716.66207.7524.1013.4826.39
PEG Ratio
1.130.661.131.091.893.25

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
2.571.962.883.221.852.85
EV/EBITDA Ratio
15.4413.1019.4221.9715.0217.60
EV/EBIT Ratio
20.8718.0426.3330.3923.8825.72
EV/FCF Ratio
37.4741.31-42.2137.27119.26

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
0.260.250.240.110.170.14
Debt / EBITDA Ratio
1.091.281.250.551.010.82
Debt / FCF Ratio
2.664.11-1.082.575.66
Net Debt / Equity Ratio
0.220.220.230.080.150.13
Net Debt / EBITDA Ratio
0.921.121.190.430.930.76
Net Debt / FCF Ratio
2.213.54-2.470.832.315.18
Asset Turnover
0.950.890.940.990.850.77
Inventory Turnover
0.950.870.961.151.150.97
Quick Ratio
0.700.650.620.820.740.52
Current Ratio
1.701.761.702.121.781.67
Return on Equity (ROE)
14.92%12.36%11.63%13.40%7.12%10.11%
Return on Assets (ROA)
7.30%6.02%6.42%6.54%4.11%5.31%
Return on Invested Capital (ROIC)
13.24%11.62%10.38%12.59%7.74%8.69%
Return on Capital Employed (ROCE)
16.30%12.90%13.60%13.20%9.60%10.90%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
4.11%5.18%3.19%3.18%3.50%3.57%
FCF Yield
2.83%2.67%-2.60%2.46%2.88%0.87%
Dividend Yield
1.15%1.81%1.18%1.12%1.61%1.35%
Payout Ratio
27.95%32.04%37.06%25.54%57.48%52.83%
Buyback Yield / Dilution
-0.05%-----1.46%
Total Shareholder Return
1.10%1.81%1.18%1.12%1.61%-0.11%